Trabectedin for desmoplastic small round cell tumours: a possible treatment option? (Q38211863)

31 August 2017

0 references

Trabectedin for desmoplastic small round cell tumours: a possible treatment option? (English)

1 reference

31 August 2017

Anna Maria Frezza

1

1 reference

31 August 2017

Jeremy S Whelan

series ordinal

2

1 reference

31 August 2017

Palma Dileo

series ordinal

3

1 reference

31 August 2017

25 April 2014

1 reference

Clinical Sarcoma Research

31 August 2017

1 reference

31 August 2017

4

1 reference

31 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1186/2045-3329-4-3

31 August 2017

0 references

cites work

Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Results of multimodal treatment for desmoplastic small round cell tumors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4019786

Intraabdominal desmoplastic small round cell tumors: a diagnostic and therapeutic challenge

6 September 2017

1 reference

12 December 2020

Activity of trabectidin in desmoplastic small round cell tumor

1 reference

12 December 2020

Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor

1 reference

12 December 2020

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/2045-3329-4-3

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference

31 August 2017

PubMed publication ID

24829745

1 reference